Robert Florczykowski is co-founder and partner at Third Dot, an investment fund focused on tech and biotech stocks; Supervisory Board member of Captor Therapeutics, publicly-listed biotech company focused on development of protein degradation drugs; Nomination Committee member of Orexo AB, publicly-listed pharmaceutical company focused on the treatment of opioid use disorder.